IN2014DN02984A - - Google Patents
Info
- Publication number
- IN2014DN02984A IN2014DN02984A IN2984DEN2014A IN2014DN02984A IN 2014DN02984 A IN2014DN02984 A IN 2014DN02984A IN 2984DEN2014 A IN2984DEN2014 A IN 2984DEN2014A IN 2014DN02984 A IN2014DN02984 A IN 2014DN02984A
- Authority
- IN
- India
- Prior art keywords
- salt
- pain
- hyperphagia
- azetidin
- eases
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 abstract 3
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 abstract 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 abstract 1
- 206010020710 Hyperphagia Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract 1
- 208000027520 Somatoform disease Diseases 0.000 abstract 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 abstract 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 125000004531 indol-5-yl group Chemical group [H]N1C([H])=C([H])C2=C([H])C(*)=C([H])C([H])=C12 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- CKJNUZNMWOVDFN-UHFFFAOYSA-N methanone Chemical compound O=[CH-] CKJNUZNMWOVDFN-UHFFFAOYSA-N 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 208000027753 pain disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161541281P | 2011-09-30 | 2011-09-30 | |
| PCT/US2012/057461 WO2013049287A1 (en) | 2011-09-30 | 2012-09-27 | Crystalline hydrochloride salt of (1- (4 -fluorophenyl) - 1h - indol - 5 - yl) - (3- (4- (thiazole - 2 - carbonyl) piperazin- 1 - yl) az etidin- 1 -yl) methanone and its use in the treatment of pain and metabolic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN02984A true IN2014DN02984A (enrdf_load_html_response) | 2015-05-15 |
Family
ID=47046853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2984DEN2014 IN2014DN02984A (enrdf_load_html_response) | 2011-09-30 | 2012-09-27 |
Country Status (11)
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1062357A (en) * | 1965-03-23 | 1967-03-22 | Pfizer & Co C | Quinazolone derivatives |
| US4337341A (en) * | 1976-11-02 | 1982-06-29 | Eli Lilly And Company | 4a-Aryl-octahydro-1H-2-pyrindines |
| US8106208B2 (en) * | 2006-05-18 | 2012-01-31 | Albireo Ab | Benzamide compounds that act as NK receptor antagonists |
| FR2915198B1 (fr) * | 2007-04-18 | 2009-12-18 | Sanofi Aventis | Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique. |
| WO2010124086A1 (en) * | 2009-04-22 | 2010-10-28 | Janssen Pharmaceutica Nv | Azetidinyl diamides as monoacylglycerol lipase inhibitors |
-
2012
- 2012-09-27 IN IN2984DEN2014 patent/IN2014DN02984A/en unknown
- 2012-09-27 MX MX2014003898A patent/MX342140B/es active IP Right Grant
- 2012-09-27 WO PCT/US2012/057461 patent/WO2013049287A1/en active Application Filing
- 2012-09-27 JP JP2014533704A patent/JP2014528427A/ja active Pending
- 2012-09-27 CN CN201280047898.7A patent/CN104271573A/zh active Pending
- 2012-09-27 US US13/628,331 patent/US8835417B2/en active Active
- 2012-09-27 KR KR1020147011475A patent/KR20140072897A/ko not_active Withdrawn
- 2012-09-27 EP EP12775377.0A patent/EP2760861A1/en not_active Withdrawn
- 2012-09-27 CA CA2849779A patent/CA2849779A1/en not_active Abandoned
- 2012-09-28 AR ARP120103634A patent/AR088198A1/es unknown
- 2012-09-28 TW TW101135724A patent/TW201329073A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR088198A1 (es) | 2014-05-14 |
| CA2849779A1 (en) | 2013-04-04 |
| WO2013049287A1 (en) | 2013-04-04 |
| US8835417B2 (en) | 2014-09-16 |
| TW201329073A (zh) | 2013-07-16 |
| CN104271573A (zh) | 2015-01-07 |
| MX2014003898A (es) | 2014-12-05 |
| US20130085279A1 (en) | 2013-04-04 |
| KR20140072897A (ko) | 2014-06-13 |
| MX342140B (es) | 2016-09-14 |
| JP2014528427A (ja) | 2014-10-27 |
| EP2760861A1 (en) | 2014-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011008276A (es) | Inhibidores de quinasa jun n-terminal. | |
| MX2012007273A (es) | Pteridinonas como inhibidores de la quinasa tipo polo. | |
| NZ603789A (en) | Heteroaryl compounds and methods of use thereof | |
| EA201001126A1 (ru) | Пирролопиримидины и пирролопиридины | |
| TN2011000282A1 (en) | Alkaloid aminoester derivatives and medicinal composition thereof | |
| AU2012258977A8 (en) | Inhibitors of LRRK2 kinase activity | |
| HK1206597A1 (en) | Spirocyclic dihydro-thiazine and dihydro-oxazine bace inhibitors, and compositions and uses thereof | |
| MX2009009590A (es) | Aminopirimidinas utiles como inhibidores de proteinas cinasas. | |
| GB0906579D0 (en) | Pharmaceuticals, compositions and methods of making and using the same | |
| IN2012DN02968A (enrdf_load_html_response) | ||
| TN2014000016A1 (en) | 4 - piperidinyl compounds for use as tankyrase inhibitors | |
| PH12015500860A1 (en) | 2-phenyl -5- heterocyclyl -tetrahydro-2h- pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders | |
| MY156332A (en) | Quinuclidine carbonate derivatives and medicinal composition thereof | |
| IL200496A0 (en) | Spirocyclic cyclohexane derivatives | |
| WO2012096929A3 (en) | Heteroaryl compounds and methods of use thereof | |
| PH12013500007A1 (en) | Piperidine derivatives and their use for the treatment of metabolic disorders | |
| MX2011006006A (es) | Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos. | |
| IN2012DN03182A (enrdf_load_html_response) | ||
| IN2014MN02380A (enrdf_load_html_response) | ||
| MX350862B (es) | Acidos de piperidinil naftilacetico. | |
| MX2010009756A (es) | Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y proceso para preparacion de los mismos. | |
| IN2013DN02555A (enrdf_load_html_response) | ||
| TN2012000191A1 (en) | Quinuclidine compounds as alpha-7nicotinic acetylcholine receptor ligands | |
| EP2195036A4 (en) | COMPOSITIONS FOR THE TREATMENT OF TUMORS BY DIRECT ADMINISTRATION OF A RADIO ISOTOPE | |
| DE602007004327D1 (de) | Einen azepin-kern enthaltende antagonisten des histaminrezeptors |